Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis

Clinical trial NCT04004416 · COMPLETED

Trial details

NCT number: NCT04004416
Sponsor: University of Michigan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Bipolar Disorder Healthy Psychosis Schizophreniform Disorders Schizo Affective Disorder Major Depression With Psychotic Features

Start date: 2020-01-16
Primary completion: 2025-02-28
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.